Corteva CTVA underwent analysis by 12 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 5 | 6 | 1 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 1 | 0 | 0 | 0 | 0 |
2M Ago | 1 | 4 | 1 | 0 | 0 |
3M Ago | 2 | 2 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $71.08, a high estimate of $74.00, and a low estimate of $64.00. This upward trend is apparent, with the current average reflecting a 3.15% increase from the previous average price target of $68.91.
Deciphering Analyst Ratings: An In-Depth Analysis
A clear picture of Corteva's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Duffy Fischer | Goldman Sachs | Announces | Buy | $71.00 | - |
Steve Byrne | B of A Securities | Raises | Buy | $73.00 | $69.00 |
Arun Viswanathan | RBC Capital | Raises | Outperform | $73.00 | $72.00 |
Kristen Owen | Oppenheimer | Raises | Outperform | $72.00 | $70.00 |
Aleksey Yefremov | Keybanc | Raises | Overweight | $70.00 | $68.00 |
Patrick Cunningham | Citigroup | Raises | Buy | $74.00 | $69.00 |
Richard Garchitorena | Wells Fargo | Raises | Overweight | $73.00 | $67.00 |
Benjamin Theurer | Barclays | Raises | Equal-Weight | $64.00 | $62.00 |
Joshua Spector | UBS | Lowers | Buy | $73.00 | $74.00 |
Aleksey Yefremov | Keybanc | Lowers | Overweight | $68.00 | $69.00 |
Arun Viswanathan | RBC Capital | Raises | Outperform | $73.00 | $68.00 |
Patrick Cunningham | Citigroup | Lowers | Buy | $69.00 | $70.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Corteva. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Corteva compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Corteva's stock. This comparison reveals trends in analysts' expectations over time.
For valuable insights into Corteva's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Corteva analyst ratings.
Get to Know Corteva Better
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
Corteva: Financial Performance Dissected
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Corteva's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 7.31%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: Corteva's net margin excels beyond industry benchmarks, reaching -1.03%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Corteva's ROE excels beyond industry benchmarks, reaching -0.17%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -0.1%, the company showcases effective utilization of assets.
Debt Management: Corteva's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.11.
Understanding the Relevance of Analyst Ratings
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.